Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.43 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.43 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.43 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.43 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | HTR7 | P34969 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | MYC | P01106 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15478649 | 0.92 | TSHR (0.43) | TSHRACHENPC1RAB9ASMN1; SMN2 | |
| SCHEMBL24521694 | 0.84 | CYP3A4 (0.54) | TSHRACHENPC1RAB9ASMN1; SMN2 | |
| SCHEMBL598761 | 0.83 | TSHR (0.53) | TSHRACHENPC1RAB9ASMN1; SMN2 | |
| SCHEMBL30354037 | 0.83 | ACHE (0.64) | TSHRACHENPC1RAB9ASMN1; SMN2 | |
| SCHEMBL30169568 | 0.83 | ACHE (0.64) | TSHRACHENPC1RAB9ASMN1; SMN2 | |
| SCHEMBL197690 | 0.83 | ACHE (0.64) | TSHRACHENPC1RAB9ASMN1; SMN2 | |
| SCHEMBL17034513 | 0.82 | HTR7 (0.42) | TSHRNPC1RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL6564122 | 0.80 | ACHE (0.60) | TSHRACHENPC1RAB9ASMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL842431 | 0.80 | ACHE (0.60) | TSHRACHENPC1RAB9ASMN1; SMN2 | |
| Lithium SCHEMBL31260773 | 0.80 | ACHE (0.60) | TSHRACHENPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116157552-A | Cyclosiloxanes and films made therefrom | 弗萨姆材料美国有限责任公司 | 2023-05-23 | — | — | CN | disclosed |
| EP-2133357-B1 | LIVING RADICAL POLYMERIZATION PROMOTER | OTSUKA CHEMICAL CO LTD (JP) | 2016-11-16 | — | — | EP | disclosed |
| US-8076430-B2 | Living radical polymerization promoter | OTSUKA CHEMICAL CO., LTD. (JP) | 2011-12-13 | — | — | US | disclosed |
| US-20100022728-A1 | LIVING RADICAL POLYMERIZATION PROMOTER | OTSUKA CHEMICAL CO., LTD. (JP) | 2010-01-28 | — | — | US | disclosed |
| EP-2133357-A1 | LIVING RADICAL POLYMERIZATION PROMOTER | Otsuka Chemical Holdings Co., Ltd. (JP) | 2009-12-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022728-A1 | LIVING RADICAL POLYMERIZATION PROMOTER | DNMT1, CYP1B1, DNMT3B | TSHR 2922/4885ACHE 1642/4885NPC1 3910/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.